Find uplifting stories about heroes, innovations, and solutions
33 results for "glp-1"
Researchers discovered genetic variants in 1 in 10 people explain why popular diabetes medications like Ozempic don't work for everyone. This breakthrough could help doctors predict treatment success and develop better alternatives.
New research reveals that GLP-1 medications like Wegovy improve heart and liver health even in patients who don't lose weight. The discovery could help millions more people access these life-changing drugs.
New research shows popular weight loss drugs like Wegovy help prevent heart attacks and heal liver disease even in people who don't lose pounds. This discovery could change how millions access life-saving treatment.
Millions of Americans now have a new option for weight management that doesn't require needles or strict meal planning. The FDA just approved Foundayo, a once-daily pill that can be taken anytime with or without food.
New research reveals genetic variants that explain why weight-loss drugs like semaglutide help some people lose 25% of their body weight while others see minimal results. The discovery could pave the way for more personalized treatments.
Scientists discovered that two genes can help predict who will lose weight on popular obesity medications and who might experience side effects. The breakthrough could personalize treatment for millions seeking help with weight loss.
Millions of Americans seeking weight loss help just got a more convenient option. The FDA approved a new daily pill that works like popular injections but without needles or strict timing rules.
A new weight-loss pill that can be taken any time of day just won FDA approval, making treatment easier for millions of Americans. The once-daily tablet offers a needle-free alternative starting at $149 monthly.
Scientists at the University of Pennsylvania have developed a way to deliver expensive diabetes drugs through genetically modified lettuce, potentially making life-changing medications affordable for millions. The breakthrough could transform how people access GLP-1 treatments that currently cost hundreds of dollars per month.
A daily pill helped patients lose 16% of their body weight in 44 weeks, outperforming other oral medications in development. The breakthrough could make obesity treatment more accessible to millions who avoid injections.
A groundbreaking VA study found that GLP-1 medications like Ozempic may reduce substance use disorders across alcohol, opioids, nicotine, and other drugs. For veterans battling addiction alongside diabetes, these findings could change everything.
A new class of medications is transforming obesity treatment by working with the body's hunger signals rather than against them, helping patients lose up to 30% of their body weight. These GLP-1 drugs are proving that obesity has deep biological roots beyond willpower alone.
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Two pharmaceutical giants just released the first truly effective weight loss pills after years of failed attempts. The new medications could make obesity treatment as easy as taking a daily tablet.
Popular diabetes medications like Ozempic may fight substance addiction by targeting the brain's reward system. A study of 600,000 veterans found users faced lower risks of developing addictions and dying from overdoses.
A massive study of 600,000 veterans found that GLP-1 medications, commonly prescribed for weight loss and diabetes, cut addiction death rates in half. The drugs also reduced the risk of developing substance abuse problems by up to 25% across multiple substances.
A medication designed for diabetes is unexpectedly quieting cravings for alcohol, nicotine, and other addictive substances, offering hope where few treatments exist. New research shows it could save thousands of lives each year.
Weight loss medications like Ozempic and Mounjaro are showing remarkable promise in fighting addiction to all major substances, from alcohol to opioids. A study of over 600,000 veterans reveals these drugs reduce substance use disorders by blocking the cravings that fuel addiction.
People taking weight loss drugs like Wegovy are successfully maintaining their results by spacing out injections to every two weeks instead of weekly. A new study shows most patients kept the weight off and their health improvements without weekly shots.
New research suggests GLP-1 medications may help treat alcohol, opioid, and drug addictions by quieting cravings in the brain. A study of 600,000 veterans found fewer ER visits and deaths across all substance types.
Showing 20 of 33